Outset Medical, Inc. Gross Profit
Outset Medical, Inc. (OM) reported Gross Profit of $13.28 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-06
- Outset Medical, Inc. gross profit for the quarter ending 2026-06-30 was $13.28M, a 11.92% increase year-over-year.
- Outset Medical, Inc. gross profit for the quarter ending 2026-03-31 was $12.10M, a 9.30% increase year-over-year.
- Outset Medical, Inc. gross profit for the quarter ending 2025-12-31 was $12.23M, a 13.81% increase year-over-year.
- Outset Medical, Inc. gross profit for the quarter ending 2025-09-30 was $11.59M, a 18.02% increase year-over-year.
- Outset Medical, Inc. gross profit for fiscal 2025 was $46.75M, a 21.24% increase from fiscal 2024.
- Outset Medical, Inc. gross profit for fiscal 2024 was $38.56M, a 32.98% increase from fiscal 2023.
- Outset Medical, Inc. gross profit for fiscal 2023 was $29.00M, a 62.62% increase from fiscal 2022.
- Outset Medical, Inc. gross profit for fiscal 2022 was $17.83M, a 134.40% increase from fiscal 2021.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.28M 10-Q · filed 2026-08-06 | $25.38M 10-Q · filed 2026-08-06 | $37.61M derived: sum of 3 quarters · filed 2026-08-06 | $49.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $12.10M 10-Q · filed 2026-05-07 | $24.33M derived: sum of 2 quarters · filed 2026-05-07 | $35.92M derived: sum of 3 quarters · filed 2026-05-07 | $47.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $12.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $23.82M derived: sum of 2 quarters · filed 2026-02-13 | $35.69M derived: sum of 3 quarters · filed 2026-08-06 | $46.75M 10-K · filed 2026-02-13 |
| 2025-09-30 | $11.59M 10-Q · filed 2025-11-10 | $23.46M derived: sum of 2 quarters · filed 2026-08-06 | $34.52M 10-Q · filed 2025-11-10 | $45.27M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $11.87M 10-Q · filed 2026-08-06 | $22.93M 10-Q · filed 2026-08-06 | $33.68M derived: sum of 3 quarters · filed 2026-08-06 | $43.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $11.07M 10-Q · filed 2026-05-07 | $21.81M derived: sum of 2 quarters · filed 2026-05-07 | $31.63M derived: sum of 3 quarters · filed 2026-05-07 | $41.41M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $10.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.57M derived: sum of 2 quarters · filed 2026-02-13 | $30.35M derived: sum of 3 quarters · filed 2026-02-13 | $38.56M 10-K · filed 2026-02-13 |
| 2024-09-30 | $9.82M 10-Q · filed 2025-11-10 | $19.60M derived: sum of 2 quarters · filed 2025-11-10 | $27.82M 10-Q · filed 2025-11-10 | $35.53M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $9.78M 10-Q · filed 2025-08-07 | $18.00M 10-Q · filed 2025-08-07 | $25.71M derived: sum of 3 quarters · filed 2026-02-13 | $32.87M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $8.21M 10-Q · filed 2025-05-08 | $15.93M derived: sum of 2 quarters · filed 2026-02-13 | $23.08M derived: sum of 3 quarters · filed 2026-02-13 | $30.79M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $14.87M derived: sum of 2 quarters · filed 2026-02-13 | $22.57M derived: sum of 3 quarters · filed 2026-02-13 | $29.00M 10-K · filed 2026-02-13 |
| 2023-09-30 | $7.16M 10-Q · filed 2024-11-07 | $14.86M derived: sum of 2 quarters · filed 2024-11-07 | $21.29M 10-Q · filed 2024-11-07 | $26.56M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $7.70M 10-Q · filed 2024-08-08 | $14.13M 10-Q · filed 2024-08-08 | $19.40M derived: sum of 3 quarters · filed 2025-02-28 | $23.74M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $6.43M 10-Q · filed 2024-05-09 | $11.70M derived: sum of 2 quarters · filed 2025-02-28 | $16.04M derived: sum of 3 quarters · filed 2025-02-28 | $19.82M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $9.61M derived: sum of 2 quarters · filed 2025-02-28 | $13.39M derived: sum of 3 quarters · filed 2025-02-28 | $17.83M 10-K · filed 2025-02-28 |
| 2022-09-30 | $4.34M 10-Q · filed 2023-11-08 | $8.12M derived: sum of 2 quarters · filed 2023-11-08 | $12.56M 10-Q · filed 2023-11-08 | $15.88M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $3.78M 10-Q · filed 2023-08-03 | $8.22M 10-Q · filed 2023-08-03 | $11.54M derived: sum of 3 quarters · filed 2024-02-21 | $14.49M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $4.44M 10-Q · filed 2023-05-04 | $7.76M derived: sum of 2 quarters · filed 2024-02-21 | $10.71M derived: sum of 3 quarters · filed 2024-02-21 | $11.76M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $6.27M derived: sum of 2 quarters · filed 2024-02-21 | $7.32M derived: sum of 3 quarters · filed 2024-02-21 | $7.61M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.95M 10-Q · filed 2022-11-09 | $4.00M derived: sum of 2 quarters · filed 2022-11-09 | $4.29M 10-Q · filed 2022-11-09 | $4.70M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.05M 10-Q · filed 2022-08-02 | $1.34M 10-Q · filed 2022-08-02 | $1.76M derived: sum of 3 quarters · filed 2022-08-02 | -$3.37M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $289.00K 10-Q · filed 2022-05-05 | $706.00K derived: sum of 2 quarters · filed 2022-05-05 | -$4.42M derived: sum of 3 quarters · filed 2022-05-05 | -$9.18M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $417.00K 10-K · filed 2021-03-22 | -$4.71M derived: sum of 2 quarters · filed 2021-11-04 | -$9.47M derived: sum of 3 quarters · filed 2021-11-04 | -$13.04M 10-K · filed 2023-02-13 |
| 2020-09-30 | -$5.13M 10-Q · filed 2021-11-04 | -$9.89M derived: sum of 2 quarters · filed 2021-11-04 | -$13.45M 10-Q · filed 2021-11-04 | -$16.23M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$4.76M 10-Q · filed 2021-08-06 | -$8.33M 10-Q · filed 2021-08-06 | -$11.11M derived: sum of 3 quarters · filed 2021-08-06 | -$16.40M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | -$3.56M 10-Q · filed 2021-05-06 | -$6.34M derived: sum of 2 quarters · filed 2021-05-06 | -$11.64M derived: sum of 3 quarters · filed 2021-05-06 | -$16.11M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | -$2.78M 10-K · filed 2021-03-22 | -$8.07M derived: sum of 2 quarters · filed 2021-03-22 | -$12.54M derived: sum of 3 quarters · filed 2021-03-22 | -$17.80M 10-K · filed 2022-02-23 |
| 2019-09-30 | -$5.29M 10-K · filed 2021-03-22 | -$9.76M derived: sum of 2 quarters · filed 2021-03-22 | -$15.02M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$4.47M 10-K · filed 2021-03-22 | -$9.73M derived: sum of 2 quarters · filed 2021-03-22 | ||
| 2019-03-31 | -$5.26M 10-K · filed 2021-03-22 | |||
| 2018-12-31 | -$6.12M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |